News

Belina Pharma

14 February, 2017

Belina is developing a new improved treatment for breast cancer. Scientists from Lund University have shown that a parallel long-term treatment with a specific drug substance in combination with today’s breast cancer treatment regimens can lead to a significantly improved treatment outcome. Belina is in a start-up phase.

Follow us on

Media contact

Sarah Fredriksson

CEO

Phone:
+46 (0)70 261 4575

Email:
sarah.fredriksson@pulsinvest.se